TabsDetailsBasic DetailsDate Posted: Monday, April 15, 2019Status: CompleteMedical Product: Lupron Depot-PEDHealth Outcome(s): central precocious pubertyDescription: The goal of this request was to characterize central precocious puberty (CPP) diagnoses and Lupron Depot-PED dispensing in the Sentinel Distributed Database (SDD). This request contains two reports. Report 1 examines the distribution of time between patients' first new diagnosis and Lupron Depot-PED dispensing. Report 2 contains counts of individuals with well child visits in the SDD.Data from January 1, 2000 to October 31, 2017 from 17 Data Partners contributing to the SDD were included in this report. This request was distributed to Data Partners on March 29, 2018. Read More Deliverables (2)Sentinel Modular Program Report: Lupron Depot-PED Use Among Patients with Central Precocious Puberty, Report 1Sentinel Modular Program Report: Lupron Depot-PED Use Among Patients with Central Precocious Puberty, Report 2Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - October 31, 2017Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: Individuals 18 years of age and youngerData Sources: Sentinel Distributed Database (SDD)Related Links: Osteoporotic Fractures Following Lupron Depot-PED Use: A Multiple Factor Matched Analysis
